Klaas J. Wardenaar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Klaas J. Wardenaar has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Robert A. Schoevers
University Medical Center Groningen
5 shared publications - Bennard Doornbos
Department of Specialist Training, GGZ Drenthe Mental Health Institute, Assen, The Netherlands
2 shared publications - Danielle C. Cath
Departments of Rijksuniversiteit Groningen and Psychiatry, University Medical Center Groninge
2 shared publications - Dennis Raven
University Center for Psychiatry, Rob Giel Research Center, Interdisciplinary Center for Psychopathology and Emotion Regulation, University Medical Center Groningen, University of Groningen, PO Box 30001, Groningen, 9700 RB, The Netherlands, 31 5036161008, 31 655257786
2 shared publications - Ellen Visser
University Medical Center Groningen, University of Groningen
2 shared publications - Erik Buskens
Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 21 July 2025
- Published by JMIR Publications Inc. in Journal of Participatory Medicine
- Vol. 17 (1) , e67170
Development of a Cocreated Decision Aid for Patients With Depression—Combining Data-Driven Prediction With Patients’ and Clinicians’ Needs and Perspectives: Mixed Methods Study
Background: Major depressive disorders significantly impact the lives of individuals, with varied treatment responses necessitating personalized approaches. Shared decision-making (SDM) enhances patient-centered care by involving patients in treatment choices. To date, instruments facilitating SDM in depression treatment are limited, particularly those that incorporate personalized information alongside general patient data and in cocreation with patients. Objective: This study outlines the development of an instrument designed to provide patients with depression and their clinicians with (1) systematic information in a digital report regarding symptoms, medical history, situational factors, and potentially successful treatment strategies and (2) objective treatment information to guide decision-making. Methods: The study was co-led by researchers and patient representatives, ensuring that all decisions regarding the development of the instrument were made collaboratively. Data collection, analyses, and tool development occurred between 2017 and 2021 using a mixed methods approach. Qualitative research provided insight into the needs and preferences of end users. A scoping review summarized the available literature on identified predictors of treatment response. K-means cluster analysis was applied to suggest potentially successful treatment options based on the outcomes of similar patients in the past. These data were integrated into a digital report. Patient advocacy groups developed treatment option grids to provide objective information on evidence-based treatment options. Results: The Instrument for shared decision-making in depression (I-SHARED) was developed, incorporating individual characteristics and preferences. Qualitative analysis and the scoping review identified 4 categories of predictors of treatment response. The cluster analysis revealed 5 distinct clusters based on symptoms, functioning, and age. The cocreated I-SHARED report combined all findings and was integrated into an existing electronic health record system, ready for piloting, along with the treatment option grids. Conclusions: The collaboratively developed I-SHARED tool, which facilitates informed and patient-centered treatment decisions, marks a significant advancement in personalized treatment and SDM for patients with major depressive disorders.
- 21 July 2025
- Published by JMIR Publications Inc. in Journal of Participatory Medicine
- Vol. 17 (1) , e67170
Open AccessDevelopment of a Cocreated Decision Aid for Patients With Depression—Combining Data-Driven Prediction With Patients’ and Clinicians’ Needs and Perspectives: Mixed Methods Study
Background: Major depressive disorders significantly impact the lives of individuals, with varied treatment responses necessitating personalized approaches. Shared decision-making (SDM) enhances patient-centered care by involving patients in treatment choices. To date, instruments facilitating SDM in depression treatment are limited, particularly those that incorporate personalized information alongside general patient data and in cocreation with patients. Objective: This study outlines the development of an instrument designed to provide patients with depression and their clinicians with (1) systematic information in a digital report regarding symptoms, medical history, situational factors, and potentially successful treatment strategies and (2) objective treatment information to guide decision-making. Methods: The study was co-led by researchers and patient representatives, ensuring that all decisions regarding the development of the instrument were made collaboratively. Data collection, analyses, and tool development occurred between 2017 and 2021 using a mixed methods approach. Qualitative research provided insight into the needs and preferences of end users. A scoping review summarized the available literature on identified predictors of treatment response. K-means cluster analysis was applied to suggest potentially successful treatment options based on the outcomes of similar patients in the past. These data were integrated into a digital report. Patient advocacy groups developed treatment option grids to provide objective information on evidence-based treatment options. Results: The Instrument for shared decision-making in depression (I-SHARED) was developed, incorporating individual characteristics and preferences. Qualitative analysis and the scoping review identified 4 categories of predictors of treatment response. The cluster analysis revealed 5 distinct clusters based on symptoms, functioning, and age. The cocreated I-SHARED report combined all findings and was integrated into an existing electronic health record system, ready for piloting, along with the treatment option grids. Conclusions: The collaboratively developed I-SHARED tool, which facilitates informed and patient-centered treatment decisions, marks a significant advancement in personalized treatment and SDM for patients with major depressive disorders.
- Open Access
- 9 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The development of a co-created decision aid for patients with depression: Combining data-driven prediction with patients’ and clinicians’ needs and perspectives (Preprint)
BACKGROUND To enable patient-centred treatment choices, shared decision-making (SDM) is essential. To date, instruments facilitating SDM in depression treatment are scarce, especially those that add personalized information, next to more general patient information. Co-creation is essential and seldom used in the development of such tools. OBJECTIVE We describe the development of an instrument that provides patients with depression and their clinicians with: (1) systematic information regarding symptoms, medical history, situational factors and potentially successful treatment strategies in a digital report and (2) objective treatment information guiding treatment decisions. METHODS The study was co-led by researchers and patient representatives, indicating all decisions regarding the development of the instrument were taken together. Data collection, analyses and tool development took place between 2017 – 2021. A mixed-methods approach was applied. Qualitative research provided insight into the end-users’ needs and preferences. A scoping review provided a summary of the available literature on identified predictors of treatment response. K-means cluster analysis was applied to suggest potentially successful treatment options based on similar patients and their outcomes in the past. These data were combined in a digital report. Treatment option grids were developed by patient advocacy groups to provide objective information on evidence-based treatment options. RESULTS The ‘Instrument for SDM in Depression’ (I-SHARED) was developed, incorporating individual characteristics and preferences. Qualitative analysis and the scoping review resulted in the identification of four categories of predictors of treatment response. The cluster analysis identified five distinct clusters based on symptoms, functioning and age. The co-created I-SHARED report combined all findings and was integrated into an existing electronic health record system ready for piloting, together with the treatment option grids. CONCLUSIONS The collaboratively developed decision aid for depression, including a clustering algorithm to predict potentially successful treatment options, has the potential to support SDM between patients and clinicians.
- 9 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe development of a co-created decision aid for patients with depression: Combining data-driven prediction with patients’ and clinicians’ needs and perspectives (Preprint)
BACKGROUND To enable patient-centred treatment choices, shared decision-making (SDM) is essential. To date, instruments facilitating SDM in depression treatment are scarce, especially those that add personalized information, next to more general patient information. Co-creation is essential and seldom used in the development of such tools. OBJECTIVE We describe the development of an instrument that provides patients with depression and their clinicians with: (1) systematic information regarding symptoms, medical history, situational factors and potentially successful treatment strategies in a digital report and (2) objective treatment information guiding treatment decisions. METHODS The study was co-led by researchers and patient representatives, indicating all decisions regarding the development of the instrument were taken together. Data collection, analyses and tool development took place between 2017 – 2021. A mixed-methods approach was applied. Qualitative research provided insight into the end-users’ needs and preferences. A scoping review provided a summary of the available literature on identified predictors of treatment response. K-means cluster analysis was applied to suggest potentially successful treatment options based on similar patients and their outcomes in the past. These data were combined in a digital report. Treatment option grids were developed by patient advocacy groups to provide objective information on evidence-based treatment options. RESULTS The ‘Instrument for SDM in Depression’ (I-SHARED) was developed, incorporating individual characteristics and preferences. Qualitative analysis and the scoping review resulted in the identification of four categories of predictors of treatment response. The cluster analysis identified five distinct clusters based on symptoms, functioning and age. The co-created I-SHARED report combined all findings and was integrated into an existing electronic health record system ready for piloting, together with the treatment option grids. CONCLUSIONS The collaboratively developed decision aid for depression, including a clustering algorithm to predict potentially successful treatment options, has the potential to support SDM between patients and clinicians.
- Open Access
- 10 July 2021
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 52 (6) , 2747-2761
Early-Life Environmental and Child Factors Associated with the Presence of Disruptive Behaviors in Seven-Year-Old Children with Autistic Traits in the Avon Longitudinal Study of Parents and Children
We studied the association of early-life environmental and child factors with disruptive behaviors in children with autistic traits around age 7, in the Avon Longitudinal Study of Parents and Children (n = 6,401). Logistic regression with the least absolute shrinkage and selection operator indicated that disruptive behaviors were associated with prenatal smoking, no seafood-consumption during pregnancy, breech presentation at delivery, neonatal feeding problems, low social-economic situation, suboptimal preschool family environment, maternal depression, maternal antisocial behavior, male sex, and difficult child temperament. Compared to controls, male sex, maternal depression, and suboptimal preschool family environment were related to autistic traits without disruptive behaviors. Thus, there may be a difference in early-life factors related to autism spectrum disorder with and without disruptive behaviors.
- 10 July 2021
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 52 (6) , 2747-2761
Open AccessEarly-Life Environmental and Child Factors Associated with the Presence of Disruptive Behaviors in Seven-Year-Old Children with Autistic Traits in the Avon Longitudinal Study of Parents and Children
We studied the association of early-life environmental and child factors with disruptive behaviors in children with autistic traits around age 7, in the Avon Longitudinal Study of Parents and Children (n = 6,401). Logistic regression with the least absolute shrinkage and selection operator indicated that disruptive behaviors were associated with prenatal smoking, no seafood-consumption during pregnancy, breech presentation at delivery, neonatal feeding problems, low social-economic situation, suboptimal preschool family environment, maternal depression, maternal antisocial behavior, male sex, and difficult child temperament. Compared to controls, male sex, maternal depression, and suboptimal preschool family environment were related to autistic traits without disruptive behaviors. Thus, there may be a difference in early-life factors related to autism spectrum disorder with and without disruptive behaviors.
- Open Access
- 11 August 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (6) , 1089-1100
Investigating data-driven biological subtypes of psychiatric disorders using specification-curve analysis
Background: Cluster analyses have become popular tools for data-driven classification in biological psychiatric research. However, these analyses are known to be sensitive to the chosen methods and/or modelling options, which may hamper generalizability and replicability of findings. To gain more insight into this problem, we used Specification-Curve Analysis (SCA) to investigate the influence of methodological variation on biomarker-based cluster-analysis results.Methods: Proteomics data (31 biomarkers) were used from patients (n = 688) and healthy controls (n = 426) in the Netherlands Study of Depression and Anxiety. In SCAs, consistency of results was evaluated across 1200 k-means and hierarchical clustering analyses, each with a unique combination of the clustering algorithm, fit-index, and distance metric. Next, SCAs were run in simulated datasets with varying cluster numbers and noise/outlier levels to evaluate the effect of data properties on SCA outcomes.Results: The real data SCA showed no robust patterns of biological clustering in either the MDD or a combined MDD/healthy dataset. The simulation results showed that the correct number of clusters could be identified quite consistently across the 1200 model specifications, but that correct cluster identification became harder when the number of clusters and noise levels increased.Conclusion: SCA can provide useful insights into the presence of clusters in biomarker data. However, SCA is likely to show inconsistent results in real-world biomarker datasets that are complex and contain considerable levels of noise. Here, the number and nature of the observed clusters may depend strongly on the chosen model-specification, precluding conclusions about the existence of biological clusters among psychiatric patients.
- 11 August 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (6) , 1089-1100
Open AccessInvestigating data-driven biological subtypes of psychiatric disorders using specification-curve analysis
Background: Cluster analyses have become popular tools for data-driven classification in biological psychiatric research. However, these analyses are known to be sensitive to the chosen methods and/or modelling options, which may hamper generalizability and replicability of findings. To gain more insight into this problem, we used Specification-Curve Analysis (SCA) to investigate the influence of methodological variation on biomarker-based cluster-analysis results.Methods: Proteomics data (31 biomarkers) were used from patients (n = 688) and healthy controls (n = 426) in the Netherlands Study of Depression and Anxiety. In SCAs, consistency of results was evaluated across 1200 k-means and hierarchical clustering analyses, each with a unique combination of the clustering algorithm, fit-index, and distance metric. Next, SCAs were run in simulated datasets with varying cluster numbers and noise/outlier levels to evaluate the effect of data properties on SCA outcomes.Results: The real data SCA showed no robust patterns of biological clustering in either the MDD or a combined MDD/healthy dataset. The simulation results showed that the correct number of clusters could be identified quite consistently across the 1200 model specifications, but that correct cluster identification became harder when the number of clusters and noise levels increased.Conclusion: SCA can provide useful insights into the presence of clusters in biomarker data. However, SCA is likely to show inconsistent results in real-world biomarker datasets that are complex and contain considerable levels of noise. Here, the number and nature of the observed clusters may depend strongly on the chosen model-specification, precluding conclusions about the existence of biological clusters among psychiatric patients.
- Open Access
- 27 July 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (7) , e14915
Mobile Mental Health Apps in China: Systematic App Store Search
Background: Smartphones have become ubiquitous in China, offering a promising way to deliver mental health interventions; however, little is known about the current use and characteristics of smartphone apps for mental health. Objective: The purpose of this study was to gain insight into mobile mental health apps available in China as of December 2018. Methods: A systematic search was conducted to identify and evaluate the most downloaded apps from iOS and Android platforms. Apps were categorized according to their main purpose and downloaded to evaluate their content. Each app’s affiliation, cost, target users, information security, and evidence-based nature were evaluated. Results: Of the 172 unique apps that were identified, there were 37 apps (21.5%) for psychological counseling, 50 apps (29.1%) for assessment, 12 apps (7.0%) to relieve stress, 24 apps (14.0%) for psychoeducation, and 49 (28.4%) multipurpose apps (ie, a combination of counseling and assessment). Most apps were developed for adults in the general population (166/172, 96.5%), rather than for psychiatric patients. App-based counseling was mostly provided by psychologists, and of the assessed apps, only 40% (70/172) used evidence-based scales to assess mental health problems such as anxiety or depressed mood. Guided meditation was used as the main technique in stress-relieving apps. Conclusions: Many apps contained useful and evidence-based elements, such as good quality information, validated measurements, and useful meditation methods; however, for mobile apps to contribute significantly to mental health care in China, considerable challenges remain, including the need for more patient-focused apps that can actually take on the role of a health care provider. In addition, efficacy studies are needed.
- 27 July 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (7) , e14915
Open AccessMobile Mental Health Apps in China: Systematic App Store Search
Background: Smartphones have become ubiquitous in China, offering a promising way to deliver mental health interventions; however, little is known about the current use and characteristics of smartphone apps for mental health. Objective: The purpose of this study was to gain insight into mobile mental health apps available in China as of December 2018. Methods: A systematic search was conducted to identify and evaluate the most downloaded apps from iOS and Android platforms. Apps were categorized according to their main purpose and downloaded to evaluate their content. Each app’s affiliation, cost, target users, information security, and evidence-based nature were evaluated. Results: Of the 172 unique apps that were identified, there were 37 apps (21.5%) for psychological counseling, 50 apps (29.1%) for assessment, 12 apps (7.0%) to relieve stress, 24 apps (14.0%) for psychoeducation, and 49 (28.4%) multipurpose apps (ie, a combination of counseling and assessment). Most apps were developed for adults in the general population (166/172, 96.5%), rather than for psychiatric patients. App-based counseling was mostly provided by psychologists, and of the assessed apps, only 40% (70/172) used evidence-based scales to assess mental health problems such as anxiety or depressed mood. Guided meditation was used as the main technique in stress-relieving apps. Conclusions: Many apps contained useful and evidence-based elements, such as good quality information, validated measurements, and useful meditation methods; however, for mobile apps to contribute significantly to mental health care in China, considerable challenges remain, including the need for more patient-focused apps that can actually take on the role of a health care provider. In addition, efficacy studies are needed.
- Open Access
- 17 June 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (1) , 112-120
Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study
Background: It has been claimed that functional somatic syndromes share a common etiology. This prospective population-based study assessed whether the same variables predict new onsets of irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS) and fibromyalgia (FM).Methods: The study included 152 180 adults in the Dutch Lifelines study who reported the presence/absence of relevant syndromes at baseline and follow-up. They were screened at baseline for physical and psychological disorders, socio-demographic, psycho-social and behavioral variables. At follow-up (mean 2.4 years) new onsets of each syndrome were identified by self-report. We performed separate analyses for the three syndromes including participants free of the relevant syndrome or its key symptom at baseline. LASSO logistic regressions were applied to identify which of the 102 baseline variables predicted new onsets of each syndrome.Results: There were 1595 (1.2%), 296 (0.2%) and 692 (0.5%) new onsets of IBS, CFS, and FM, respectively. LASSO logistic regression selected 26, 7 and 19 predictors for IBS, CFS and FM, respectively. Four predictors were shared by all three syndromes, four predicted IBS and FM and two predicted IBS and CFS but 28 predictors were specific to a single syndrome. CFS was more distinct from IBS and FM, which predicted each other.Conclusions: Syndrome-specific predictors were more common than shared ones and these predictors might form a better starting point to unravel the heterogeneous etiologies of these syndromes than the current approach based on symptom patterns. The close relationship between IBS and FM is striking and requires further research.
- 17 June 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (1) , 112-120
Open AccessPredictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study
Background: It has been claimed that functional somatic syndromes share a common etiology. This prospective population-based study assessed whether the same variables predict new onsets of irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS) and fibromyalgia (FM).Methods: The study included 152 180 adults in the Dutch Lifelines study who reported the presence/absence of relevant syndromes at baseline and follow-up. They were screened at baseline for physical and psychological disorders, socio-demographic, psycho-social and behavioral variables. At follow-up (mean 2.4 years) new onsets of each syndrome were identified by self-report. We performed separate analyses for the three syndromes including participants free of the relevant syndrome or its key symptom at baseline. LASSO logistic regressions were applied to identify which of the 102 baseline variables predicted new onsets of each syndrome.Results: There were 1595 (1.2%), 296 (0.2%) and 692 (0.5%) new onsets of IBS, CFS, and FM, respectively. LASSO logistic regression selected 26, 7 and 19 predictors for IBS, CFS and FM, respectively. Four predictors were shared by all three syndromes, four predicted IBS and FM and two predicted IBS and CFS but 28 predictors were specific to a single syndrome. CFS was more distinct from IBS and FM, which predicted each other.Conclusions: Syndrome-specific predictors were more common than shared ones and these predictors might form a better starting point to unravel the heterogeneous etiologies of these syndromes than the current approach based on symptom patterns. The close relationship between IBS and FM is striking and requires further research.
- Open Access
- 1 October 2019
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 62, 90-96
Trajectories and determinants of functional limitations in late-life depression: A 2-year prospective cohort study
Background: In mental health research, functional recovery is increasingly valued as an important outcome in addition to symptomatic remission.Methods: Course types of functional limitations among depressed older patients and its relation with symptomatic remission were explored in a naturalistic cohort study (Netherlands Study of Depression in Older persons). 378 depressed older patients (≥60 years) and 132 non-depressed persons were included. Depressive disorders were assessed with Composite International Diagnostic Interview at baseline and two-year follow-up. Functional limitations were assessed every 6 months with the World Health Organization Disability Assessment II.Results: Depressed patients had more functional limitations compared to their non-depressed counterparts. Growth Mixture Modeling among depressed patients identified two trajectories of functional limitations, both starting at a high disability level. The largest subgroup (81.2%) was characterized by a course of high disability levels over time. The smaller subgroup (18.8%) had an improving course (functional recovery). After two years, the main predictor of functional recovery was the remission of depression. Among symptomatic remitted patients, female sex, higher level of education, higher gait speed, and less severe depression were associated with no functional recovery. Non-remitted patients without functional recovery were characterized by the presence of more chronic somatic diseases, a lower sense of mastery, and a higher level of anxiety.Conclusions: 1 in 5 depressed older patients have a course with functional recovery. Combining functional and symptomatic recovery points to a subgroup of older patients that might profit from more rigorous psychiatric treatment targeted at psychiatric comorbidity and a group of frail depressed older patients that might profit from integrated geriatric rehabilitation.
- 1 October 2019
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 62, 90-96
Open AccessTrajectories and determinants of functional limitations in late-life depression: A 2-year prospective cohort study
Background: In mental health research, functional recovery is increasingly valued as an important outcome in addition to symptomatic remission.Methods: Course types of functional limitations among depressed older patients and its relation with symptomatic remission were explored in a naturalistic cohort study (Netherlands Study of Depression in Older persons). 378 depressed older patients (≥60 years) and 132 non-depressed persons were included. Depressive disorders were assessed with Composite International Diagnostic Interview at baseline and two-year follow-up. Functional limitations were assessed every 6 months with the World Health Organization Disability Assessment II.Results: Depressed patients had more functional limitations compared to their non-depressed counterparts. Growth Mixture Modeling among depressed patients identified two trajectories of functional limitations, both starting at a high disability level. The largest subgroup (81.2%) was characterized by a course of high disability levels over time. The smaller subgroup (18.8%) had an improving course (functional recovery). After two years, the main predictor of functional recovery was the remission of depression. Among symptomatic remitted patients, female sex, higher level of education, higher gait speed, and less severe depression were associated with no functional recovery. Non-remitted patients without functional recovery were characterized by the presence of more chronic somatic diseases, a lower sense of mastery, and a higher level of anxiety.Conclusions: 1 in 5 depressed older patients have a course with functional recovery. Combining functional and symptomatic recovery points to a subgroup of older patients that might profit from more rigorous psychiatric treatment targeted at psychiatric comorbidity and a group of frail depressed older patients that might profit from integrated geriatric rehabilitation.
- Open Access
- 3 June 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Mobile Mental Health Apps in China: Systematic App Store Search (Preprint)
BACKGROUND Smartphones have become ubiquitous in China, offering a promising way to deliver mental health interventions; however, little is known about the current use and characteristics of smartphone apps for mental health. OBJECTIVE The purpose of this study was to gain insight into mobile mental health apps available in China as of December 2018. METHODS A systematic search was conducted to identify and evaluate the most downloaded apps from iOS and Android platforms. Apps were categorized according to their main purpose and downloaded to evaluate their content. Each app’s affiliation, cost, target users, information security, and evidence-based nature were evaluated. RESULTS Of the 172 unique apps that were identified, there were 37 apps (21.5%) for psychological counseling, 50 apps (29.1%) for assessment, 12 apps (7.0%) to relieve stress, 24 apps (14.0%) for psychoeducation, and 49 (28.4%) multipurpose apps (ie, a combination of counseling and assessment). Most apps were developed for adults in the general population (166/172, 96.5%), rather than for psychiatric patients. App-based counseling was mostly provided by psychologists, and of the assessed apps, only 40% (70/172) used evidence-based scales to assess mental health problems such as anxiety or depressed mood. Guided meditation was used as the main technique in stress-relieving apps. CONCLUSIONS Many apps contained useful and evidence-based elements, such as good quality information, validated measurements, and useful meditation methods; however, for mobile apps to contribute significantly to mental health care in China, considerable challenges remain, including the need for more patient-focused apps that can actually take on the role of a health care provider. In addition, efficacy studies are needed.
- 3 June 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMobile Mental Health Apps in China: Systematic App Store Search (Preprint)
BACKGROUND Smartphones have become ubiquitous in China, offering a promising way to deliver mental health interventions; however, little is known about the current use and characteristics of smartphone apps for mental health. OBJECTIVE The purpose of this study was to gain insight into mobile mental health apps available in China as of December 2018. METHODS A systematic search was conducted to identify and evaluate the most downloaded apps from iOS and Android platforms. Apps were categorized according to their main purpose and downloaded to evaluate their content. Each app’s affiliation, cost, target users, information security, and evidence-based nature were evaluated. RESULTS Of the 172 unique apps that were identified, there were 37 apps (21.5%) for psychological counseling, 50 apps (29.1%) for assessment, 12 apps (7.0%) to relieve stress, 24 apps (14.0%) for psychoeducation, and 49 (28.4%) multipurpose apps (ie, a combination of counseling and assessment). Most apps were developed for adults in the general population (166/172, 96.5%), rather than for psychiatric patients. App-based counseling was mostly provided by psychologists, and of the assessed apps, only 40% (70/172) used evidence-based scales to assess mental health problems such as anxiety or depressed mood. Guided meditation was used as the main technique in stress-relieving apps. CONCLUSIONS Many apps contained useful and evidence-based elements, such as good quality information, validated measurements, and useful meditation methods; however, for mobile apps to contribute significantly to mental health care in China, considerable challenges remain, including the need for more patient-focused apps that can actually take on the role of a health care provider. In addition, efficacy studies are needed.